ARS Pharmaceuticals, Inc.SPRYNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank57
3Y CAGR-71.3%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-71.3%/yr
Quarterly compound
Percentile
P57
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 2.37% |
| Q3 2025 | 126.50% |
| Q2 2025 | 173.31% |
| Q1 2025 | -95.25% |
| Q4 2024 | 4127.45% |
| Q3 2024 | 291.20% |
| Q2 2024 | 109.55% |
| Q1 2024 | -53.76% |
| Q4 2023 | -13.39% |
| Q3 2023 | 58.29% |
| Q2 2023 | -11.91% |
| Q1 2023 | 0.00% |
| Q4 2022 | 100.00% |
| Q3 2022 | 7.26% |
| Q2 2022 | 18.36% |
| Q1 2022 | -50.63% |
| Q4 2021 | 31.21% |
| Q3 2021 | -31.01% |
| Q2 2021 | 0.00% |
| Q1 2021 | -654.09% |
| Q4 2020 | 0.00% |
| Q2 2020 | -0.50% |
| Q1 2020 | -1.52% |
| Q4 2019 | 0.00% |